Zobrazeno 1 - 10
of 33
pro vyhledávání: '"L A Haisheva"'
Autor:
I E Chazova, T V Martynyuk, R Accetto, Yu N Sirenko, J Vincelj, Jr Widimsky, B Barbič-Žagar, M V Arhipov, Yu I Grinshtein, O D Ostroumova, A S Galjavich, O P Rotar, L A Haisheva, S V Nedogoda
Publikováno v:
Системные гипертензии, Vol 15, Iss 2, Pp 6-13 (2018)
Objective - to explore influence of valsartan monotherapy use and its use in combination with hydrochlorothiazide (HCTZ) on pulse-wave velocity (PWV) and central arterial pressure (CAP) in patients with arterial hypertension (AH) of 1-2 grades in int
Externí odkaz:
https://doaj.org/article/e87da0776e7b41f1acf4aac2ea0d9f37
Autor:
I E Chazova, T V Martynyuk, R Accetto, Yu Sirenko, J Vincelj, Jr JWidimsky, B Barbič-Žagar, M V Arhipov, Yu I Grinshtein, O D Ostroumova, A S Galjavich, O P Rotar', L A Haisheva, S V Nedogoda
Publikováno v:
Системные гипертензии, Vol 14, Iss 2, Pp 80-89 (2017)
Objective. The VICTORY study aimed to evaluate effectiveness and safety of monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in clinical practice in patients with stage 1 and stage 2 hypertensio
Externí odkaz:
https://doaj.org/article/61c6fb1afe6e4d50bb09da4218139fcd
Autor:
I. E. Chazova, T. V. Martynyuk, V. O. Rodnenkov, B. Sh. Gorieva, A. N. Rogoza, M. V. Arkhipov, Yu. I. Grinshtein, O. D. Ostroumova, A. S. Galiavich, O. P. Rotar’, L. A. Haisheva, T. R. Kameneva
Publikováno v:
Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)
Abstract VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter
Externí odkaz:
https://doaj.org/article/d10d2629c2744a8cb865611fbf570069
Publikováno v:
South Russian Journal of Therapeutic Practice. 3:55-62
Objective: To assess the relationship of arrhythmic events such as supraventricular arrhythmias and asymptomatic arrhythmias and their long-term association with adverse events among patients undergoing chronic hemodialysis.Materials and methods: a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e8c4d3c3265a719e5be302fd95cece2
https://doi.org/10.21886/2712-8156-2022-3-2-55-62
https://doi.org/10.21886/2712-8156-2022-3-2-55-62
Autor:
L. A. Haisheva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 27-32 (2016)
Aim. To study endothelial disorders and artery elasticity disorders in patients with arterial hypertension (HT), as well as possibility of their correction by lisinopril or by fixed low dose combination of lisinopril and hydrochlorothiazide.Material
Externí odkaz:
https://doaj.org/article/674b892be8284027ac70e33b8b08d50d
Publikováno v:
Klinicist, Vol 6, Iss 1, Pp 26-30 (2014)
Aim — cross-sectional study of changes in various segments of the vascular bed in arterial hypertension (AH), defining the role of inducers and inhibitors of angiogenesis in these processes.Materials and methods. The study included 99 patients with
Externí odkaz:
https://doaj.org/article/edbfa4f8822446a086c7d7213daf2a3e
Autor:
L A Haisheva, A. N. Rogoza, Yu. I. Grinshtein, Olga D. Ostroumova, O. P. Rotar, A. S. Galiavich, B. Sh. Gorieva, I E Chazova, M. V. Arkhipov, T. R. Kameneva, V. O. Rodnenkov, Tamila Martynyuk
Publikováno v:
Системные гипертензии, Vol 17, Iss 2, Pp 36-47 (2020)
VICTORY II study objective. Evaluation of Vamloset and Co-Vamloset safety and effectiveness in reaching target blood pressure (BP) level in patients with stages 23 arterial hypertension (AH). Materials and methods. Russian multicenter prospective cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63bda42a6d834674883f8ecc0ca55334
https://doi.org/10.26442/2075082x.2020.2.200123
https://doi.org/10.26442/2075082x.2020.2.200123
Autor:
Rok Accetto, L A Haisheva, Barbič-Žagar Breda, J Vincelj, A S Galjavich, S. V. Nedogoda, Vincelj Josip, Widimsky Jiri, Accetto Rok, O. P. Rotar, Jr Widimsky, Yu N Sirenko, Tamila Martynyuk, Yu. I. Grinshtein, Olga D. Ostroumova, I E Chazova, M V Arhipov, Sirenko Yuriy N, B Barbič-Žagar
Publikováno v:
Системные гипертензии, Vol 15, Iss 2, Pp 6-13 (2018)
Objective - to explore influence of valsartan monotherapy use and its use in combination with hydrochlorothiazide (HCTZ) on pulse-wave velocity (PWV) and central arterial pressure (CAP) in patients with arterial hypertension (AH) of 1-2 grades in int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a95b826e195e03d45c89c84312ca9ab
https://doi.org/10.26442/2075-082x_2018.2.6-13
https://doi.org/10.26442/2075-082x_2018.2.6-13
Autor:
Sirenko Yu, O. P. Rotar, Rok Accetto, Tamila Martynyuk, A S Galjavich, Olga D. Ostroumova, B Barbič-Žagar, M V Arhipov, Jr JWidimsky, J Vincelj, S. V. Nedogoda, Yu N Sirenko, JWidimsky, L A Haisheva, Yu I Grinshtein, I E Chazova
Publikováno v:
Systemic Hypertension. 14:80-89
Objective. The VICTORY study aimed to evaluate effectiveness and safety of monotherapy with valsartan (Valsacor®) and its fixed combination with hydrochlorothiazide (Valsacor® H) in clinical practice in patients with stage 1 and stage 2 hypertensio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e3b512a7713f525285511b3d1e4350d
https://doi.org/10.26442/sg29204
https://doi.org/10.26442/sg29204
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 5, Iss 4, Pp 45-50 (2016)
Aim. Clinico-economical analysis of arterial hypertension (HT) treatmentMaterial and methods. 78 patients with HT were involved into the study. Patients were spitted into two groups depending on HT degree. The first group – 38 patients with HT 1 de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a91dc1ed2ab6af6060ff2532110f576a
http://www.rpcardio.ru/jour/article/view/685
http://www.rpcardio.ru/jour/article/view/685